MYELOMA

HCI 25009
"Tandem Autotransplantation for Multiple Myeloma Patients with less than 12 months of Preceding Therapy, Incorporating bortezomib with the Transplant Chemotherapy and During Maintenance"

HCI 26679
"Phase I Study of Disulfiram and Copper Gluconate for the Treatment of Refractory Solid Tumors Involving the Liver"

HCI 32829
"Phase I Exploratory Study of Panobinostat IV in Combination with Bortezomib in Relapsed/Refractory Multiple Myeloma Patients"

HCI 32857
"A Phase I/II Open Label Study of IV Busulfan (Busulfex®) in Multiple Myeloma Patients 65 years of Age or Older, or with Renal Insufficiency undergoing Autologous Transplantation"

HCI 33979
"Effect of Low Dose Bortezomib on Bone Formation in Smoldering Myeloma Patients"

HCI 35383
"BioInvent 08-BI-505-01: A Phase I Dose-Escalation Study to Determine the Safety, Pharmacokinetics, and Pharmacodynamics of BI-505, a Human Anti–Intercellular Adhesion Molecule-1 Monoclonal Antibody, in Patients with Advanced Multiple Myeloma"

HCI 35813
"Bone Effect of Bortezomib in Patients with relapsed/refractory Multiple Myeloma"

HCI 36662
"A Phase I Open-Label, Multiple Dose, Dose Escalation Study of ACE-401 in Patients with Advanced Solid Tumors or Relapsed/Refractory Multiple Myeloma "